Table 1.
Median (IQR) | Number (%) | |
---|---|---|
Gender | ||
Male | 53 (51) | |
Female | 51 (49) | |
Age at surgery, year 55 (47–63) | ||
Race | ||
Caucasian | 90 (86) | |
African American | 6 (6) | |
Hispanic | 4 (4) | |
Asian | 3 (3) | |
Other | 1 (1) | |
CACI 3 (1–5) | ||
Functional | ||
Yes | 9 (9) | |
No | 95 (91) | |
Tumor size, cm 2.8 (2.0–4.5) | ||
WHO grade | ||
1 | 57 (55) | |
2 | 47 (45) | |
Mitotic count /10HPF 0.2 (0.0–2.0) | ||
Ki67 labeling index, % 2.0 (1.2–3.2) | ||
T stage | ||
1 | 27 (26) | |
2 | 59 (57) | |
3 | 16 (15) | |
4 | 2 (2) | |
Lymph node positivity | ||
Yes | 18 (17) | |
No | 86 (83) | |
Clavien-Dindo grade (90 days) | ||
0-II | 84 (81) | |
III-V | 20 (19) |
IQR: interquartile range; CACI: Charlson Age Comorbidity Index; HPF: high-power field